Table 3.
Proportional treatment contact in the year of onset of any substance use disorder and median duration of delay among cases that subsequently made treatment contact
| Making treatment contact in year of onset, % (SE) | Making treatment contact by 50 years, % (SE) | Median duration of delay in years (SE) | |
|---|---|---|---|
| The Americas | |||
| Colombia | 3.6 (0.8) | 123.1 (7.1) | 11.0 (5.0) |
| Mexico | 0.9 (0.5) | 122.1 (4.8) | 10.0 (3.3) |
| USA a | 10.0 (0.8) | 175.5 (3.8) | 13.0 (1.2) |
| Europe | |||
| Belgium | 12.8 (4.8) | 61.2 (17.7) | 18.0 (5.8) |
| France | 15.7 (5.4) | 66.5 (14.1) | 13.0 (3.7) |
| Germany | 13.2 (5.7) | 186.1 (8.6) | 9.0 (3.9) |
| Italy | -b | -b | -b |
| Netherlands | 15.5 (5.4) | 166.6 (7.9) | 9.0 (3.1) |
| Spain | 18.6 (7.6) | 40.1 (14.1) | 6.0 (4.9) |
| Africa and Middle East | |||
| Israel | 2.0 (0.5) | 148.0 (2.4) | 12.0 (0.5) |
| Lebanon a | -b | -b | -b |
| Nigeria a | 2.8 (1.7) | 19.8 (7.2) | 8.0 (1.8) |
| Asia and the Pacific | |||
| Japan a | 9.2 (5.1) | 31.0 (7.8) | 8.0 (4.6) |
| PR China a | 2.8 (1.8) | 25.7 (9.0) | 17.0 (3.7) |
| Oceania | |||
| New Zealand | 6.3 (0.8) | 84.8 (15.4) | 17.0 (1.3) |
a Assessed in the part II sample
b Disorder was omitted due to insufficient cases (n<30)